glp-1 long-term use safety Safety: GI Risks After 3 Years Safety risks in the GLP-1

What Needs to Be in Place Before a First-in-Human Trial Begins Before entering a First-in-Human trial, a drug candidate must be supported by a comprehensive package of scientific, non-clinical and quality evidence

many have not

Keep the bottle tightly closed and protect from light

Patients are asking about Ozempic, Wegovy, Mounjaro, Zepbound, semaglutide, tirzepatide, and newer medications because these treatments may help with appetite control, fullness, and weight-related health goals when used under proper medical supervision

And so thats one of my worries with these peptides, is that theyll kind of encourage moving along the pathway towards an actual cancer. The larger problem is that researchers lack the human data needed to measure either the risk or the claimed benefit